Aveanna Healthcare Holdings Inc.

Aveanna Healthcare Holdings Inc.

AVAHNYSE / NASDAQHealthcareSmall cap

$11.01+$0.31 (+2.9%)

Last close · Data as of Nov 20, 2026

Market cap
$1.4B
P/E
6.4x
EV / EBITDA
10.3x
Revenue
$2.4B
Net margin
9.2%
ROCE
16.4%

+32.7% over the last year

Aveanna Healthcare Holdings Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
-13.6%
3M
-15.1%
6M
+43.4%
1Y
+32.7%
5Y
+49.2%

52-week range

Day change +$0.31 (+2.9%) from $10.70 to $11.01 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in AVAH, bought on each weekday since 2021.

News & filings

What Aveanna Healthcare Holdings filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

ConcernOperating profit was 1.8 times interest costs.

Strengths (1)

  • Return on capital employed of 16.4%.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.

Read moreShow less

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically complex children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Sector
Healthcare
Shares outstanding
211.0M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$1.4B
P/E
6.4x
P/B
7.4x
EV / EBITDA
10.3x
EV / Sales
1.1x
P/S
0.6x
52-week high
$14.38
52-week low
$6.22

Profitability

Operating margin
10.7%
Net margin
9.2%
EBITDA margin
11.1%
ROE
115.3%
ROCE
16.4%
ROIC
15.9%
ROA
11.2%
Asset turnover
1.21

Growth

Revenue
$2.4B
Revenue growth, 1Y
20.2%
Revenue CAGR, 3Y
10.8%
Net profit growth, 1Y
-2159.1%
Free cash flow
$118.4M

Solvency

Current ratio
1.32
Debt / Equity
7.76
Debt / Assets
0.75
CFO / Net profit
0.56
Cash / Market cap
13.4%

Where the revenue went

Of every $100 of FY2025 revenue, $9 was left as net income.

Aveanna Healthcare Holdings Inc. income statement flow, FY2025
Aveanna Healthcare Holdings Inc. income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$1.6B
RevenueGross profit$810.5M
Gross profitSelling, general and administrative$528.8M
Gross profitOther operating expenses$21.4M
Gross profitOperating income$260.3M
Operating incomePretax income$107.0M
Operating incomeInterest and other expense$153.3M
Pretax incomeNet income$107.0M
Tax benefit and otherNet income$118.1M

Revenue and net profit

Revenue grew 20.2% in FY2025; net profit is the dashed line.

Aveanna Healthcare Holdings Inc. revenue and net profit by fiscal year
Aveanna Healthcare Holdings Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$1.8B-$662.0M
FY2023$1.9B-$134.5M
FY2024$2.0B-$10.9M
FY2025$2.4B$225.0M

Cash flows

FY2025: $125.9M from operations, $118.4M free after investment (dashed).

Aveanna Healthcare Holdings Inc. operating and free cash flow by fiscal year
Aveanna Healthcare Holdings Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022-$48.4M-$60.4M
FY2023$22.7M$13.9M
FY2024$32.6M$26.3M
FY2025$125.9M$118.4M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$2.4B+20.2%1Y
EBITDA
$269.4M+43.8%1Y
Net profit
$225.0M
Cash from operations
$125.9M+285.6%1Y
Free cash flow
$118.4M+349.9%1Y
Revenue CAGR, 3Y
10.8%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$2.4B$269.4M$225.0M$118.4M115.3%+20.2%-2159.1%

Monthly returns

Month-by-month returns of AVAH across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$2.0B
Liabilities$1.8B
Equity$195.2M
Paid-in capital$1.3B
Retained earnings-$1.2B

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; AVAH highlighted.

P/E against peers

AVAH trades at 6.4x earnings against a peer median of -15.3x.

  1. Aveanna Healthcare Holdings Inc. (this company)6.4x

EV / Sales, for the companies without earnings

Not shown (no positive earnings and no EV / Sales): MBX Biosciences, Inc., Maze Therapeutics, Inc.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
Aveanna Healthcare Holdings Inc.AVAHthis company$1.4B6.4x7.4x115.3%10.3x
STAAR Surgical CompanySTAA$1.5B-18.5x4.3x-23.4%-36.9x
Perrigo Company plcPRGO$1.5B-1.0x0.5x-48.6%-5.7x
NeoGenomics, Inc.NEO$1.5B-13.6x1.8x-12.9%-44.5x
MBX Biosciences, Inc.MBX$1.5B-16.9x4.0x-23.6%-14.3x
Monte Rosa Therapeutics, Inc.GLUE$1.5B-38.0x6.3x-16.6%-30.0x
Septerna, Inc.SEPN$1.4B-28.9x3.7x-12.8%-16.6x
Maze Therapeutics, Inc.MAZE$1.4B-10.7x4.0x-36.9%-8.8x
Healthcare Services Group, Inc.HCSG$1.4B23.8x2.8x11.6%14.9x
Peer median—-15.3x3.8x-20.0%-15.5x

Year-to-date ROI

AVAH since 1 January, against earlier years.

Historical volatility

AVAH's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

Aveanna Healthcare Holdings Inc. operating margin by fiscal year
Aveanna Healthcare Holdings Inc. operating margin by fiscal year
DateOperating margin
FY20221.9%
FY20236.0%
FY20247.0%
FY202510.7%
LineFY2025
Cost of revenueCost Of Revenue$1.6B
Gross profitGross Profit$810.5M
Operating expensesOperating Expense$550.2M
Other operating expensesOther Operating Expenses$10.9M
Depreciation and amortisationDepreciation And Amortization In Income Statement$10.5M
Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement$10.5M
Rent expense supplementalRent Expense Supplemental$13.5M
Total expensesTotal Expenses$2.2B
Pretax incomePretax Income$107.0M

Learn while you research

Academy chapters picked for Aveanna Healthcare Holdings Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Value InvestingA P/E of 6.4 could be a value opportunity, or a value trap. Know the difference.7 min read
  3. 03 Growth Investing20% revenue growth is in the top tier, learn how to value growth.7 min read
  4. 04 Leverage RatiosDebt/Equity of 7.76 is elevated, understand what that means for solvency.6 min read
  5. 05 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
  6. 06 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
Browse the full Equiscale Academy →